Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-11-08

Clinical Trial Update: The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial comparing vascular effects of exenatide versus metformin in adults with impaired glucose tolerance; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BYETTA (Exenatide)
  • Glucophage (metformin)

Snippet

Sponsor: St. Paul Heart Clinic | Conditions: Impaired Glucose Tolerance | Phase 4 | Status: COMPLETED | Results posted: 2013-11-08